# Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)

> **NCT05416320** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Wake Forest University Health Sciences**

## Conditions studied

- Central Centrifugal Cicatricial Alopecia

## Interventions

- **DRUG:** Calcipotriol
- **DRUG:** Subject's already prescribed drug

## Key facts

- **NCT ID:** NCT05416320
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-08
- **Primary completion:** 2023-11
- **Final completion:** 2023-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The IRB was closed without enrolling any participants
- **Last updated:** 2023-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05416320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05416320, "Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05416320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*